Thrilled to see VSPARTICLE featured in The Economist for shaping the future of AI-driven materials discovery & creation! economist.com/science-and-te…

Congratulations to Marvel Fusion on the successful $120M raise - a key milestone that brings total funding to $415M. We are excited to continue supporting their quest for commercializing fusion-enabled baseload energy to power the world’s clean energy future.

We've always been a PR / comms-shy firm, preferring to work in the background. But our portfolio companies and founders have too many great stories for them to be left untold. We are therefore looking to add a Head of Communications / PR to our team, to help unlock the powerful

The future of manufacturing is autonomous, powered by AI factory operating systems. That’s no longer a prediction: it’s happening with Manex AI (manex.ai/en, ex DatagonAI). They are already working with BMW, Stellantis & others to integrate AI into production.

This helps redefine what a molecule is & that blows my mind. arxiv.org/abs/2408.09171

Congratulations Henri Stern Ꙫ, Asta Li & the entire Privy team on their acquisition by Stripe. Supporting 75m accounts, over 1k+ developer teams and billions of transactions - Privy is a key enabling fabric for a plethora of crypto rails-based applications. We are ecstatic

Congratulations team Privy on their acquisition by Stripe! 75m accounts, over 1k+ developer teams and billions of transactions - Privy is a key enabling fabric for crypto rails-based applications. It’s been an honor to have been on the journey with Henri Stern Ꙫ Asta Li

So we opened our Chemifarm today! chemify.io

1/ Big news from Sensible Biotechnologies: we’ve partnered with Sartorius to scale up our cell-based mRNA design and manufacturing platform. A major step forward for Sensible! 🧵👇

Are you a seed-stage founder / builder (or soon to be) working on the hard frontier of AI? Then apply to join Climbing Hard AI Peaks, an immersive two-day summit for learning and exchange: blueyard.medium.com/climbing-hard-…

Chemputation will lead to an exponential growth of the number of molecules synthetically accessible. It transcends the limits of manual labor by using a Turing-like ontology for error correction to ensure we can go deeper into chemical space. arxiv.org/abs/2408.09171

Big news 🎉 Michael Boehler, MD joins clock.bio as Chief Business Officer! 👉 Ex-BioNTech exec who built its global commercial org 👉 Senior roles at Takeda, Kite & Amgen 👉 Now driving rejuvenation biology to extend human healthspan 🔗 prnewswire.com/news-releases/…

We're excited for the launch of Recall - similar to how the early internet required search engines and reputation systems of a website’s trust scores, AI also needs that trust layer. On Recall AI can prove their worth onchain

Today we’re proud to share that BlueYard led the $24M Series A for Corintis, supporting their mission to unlock the next step function growth in compute power through better cooling of chips. medium.com/p/cooling-the-…

After Ochre Bio, Jack O’Meara is back with Aerska — a neuro-focused biotech that just raised $21M to speed siRNAs into the clinic. endpoints.news/after-building…

We’re excited to be backing Jack O'Meara and the entire Aerska team on their mission to develop RNAi therapies that cross the blood–brain barrier—tackling neurology’s toughest bottleneck. More from Kyle LaHucik on their $21M seed round: endpoints.news/after-building…

If medicines can reliably cross the blood–brain barrier, then the way we treat neurological disease changes forever. Excited to be backing Jack O'Meara and the entire team at @Aerska on their mission to tackle neurology’s toughest bottleneck x.com/blueyard/statu…

AI that builds the physical world: Chemify’ s Chemputation platform turns digital code into molecules, redefining how chemistry & manufacturing scale. BlueYard Capital is excited to continue backing Prof. Lee Cronin & team as they raise $50M to build the global network of Chemifarms

Joining @BlueYard as General Partner and excited to support founders tackling hard, meaningful problems in AI, resilience & energy or infrastructure. Proud to join Ciarán O'Leary, David Byrd, Jason Whitmire and chad fowler who've been quietly backing some of the most ambitious

From an idea at an Irish pub to life-changing technology – Jack O'Meara, CEO of Aerska, shares with Ashley Mastronardi how the company is helping patients around the world with breakthrough innovation. 📺 Watch full interview here: youtu.be/F40ypr9BR5A ➡️ Follow NYSE 🏛 & download NYSE